We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Respiratory Medicine

Journal Scan / Research · August 30, 2022

Balloon Pulmonary Angioplasty vs Riociguat for Inoperable Chronic Thromboembolic Pulmonary Hypertension

The Lancet Respiratory Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Respiratory Medicine
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study
Lancet Respir Med 2022 Aug 01;[EPub Ahead of Print], X Jaïs, P Brenot, H Bouvaist, M Jevnikar, M Canuet, C Chabanne, A Chaouat, V Cottin, P De Groote, N Favrolt, D Horeau-Langlard, P Magro, L Savale, G Prévot, S Renard, O Sitbon, F Parent, R Trésorier, C Tromeur, C Piedvache, L Grimaldi, E Fadel, D Montani, M Humbert, G Simonneau

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading